Creative Planning’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $63.6M | Buy |
129,348
+5,093
| +4% | +$2.76M | 0.04% | 182 |
|
|
2025
Q4 | $72M | Buy |
124,255
+1,459
| +1% | +$825K | 0.05% | 156 |
|
|
2025
Q3 | $59.6M | Buy |
122,796
+11,027
| +10% | +$5.13M | 0.05% | 160 |
|
|
2025
Q2 | $45.3M | Buy |
111,769
+9,086
| +9% | +$3.8M | 0.04% | 189 |
|
|
2025
Q1 | $51.1M | Sell |
102,683
-1,743
| -2% | -$944K | 0.05% | 154 |
|
|
2024
Q4 | $54.3M | Buy |
104,426
+3,252
| +3% | +$1.79M | 0.05% | 136 |
|
|
2024
Q3 | $62.6M | Buy |
101,174
+3,072
| +3% | +$1.82M | 0.06% | 120 |
|
|
2024
Q2 | $54.3M | Buy |
98,102
+2,668
| +3% | +$1.53M | 0.06% | 126 |
|
|
2024
Q1 | $55.5M | Buy |
95,434
+6,428
| +7% | +$3.61M | 0.06% | 122 |
|
|
2023
Q4 | $47.2M | Sell |
89,006
-27,935
| -24% | -$13.5M | 0.09% | 126 |
|
|
2023
Q3 | $59.2M | Buy |
116,941
+36,587
| +46% | +$19.5M | 0.08% | 111 |
|
|
2023
Q2 | $41.9M | Sell |
80,354
-1,918
| -2% | -$1.04M | 0.06% | 130 |
|
|
2023
Q1 | $47.4M | Buy |
82,272
+1,641
| +2% | +$925K | 0.07% | 119 |
|
|
2022
Q4 | $44.4M | Buy |
80,631
+6,469
| +9% | +$3.43M | 0.07% | 122 |
|
|
2022
Q3 | $37.6M | Sell |
74,162
-4,773
| -6% | -$2.67M | 0.07% | 119 |
|
|
2022
Q2 | $42.9M | Buy |
78,935
+6,275
| +9% | +$3.45M | 0.07% | 116 |
|
|
2022
Q1 | $42.9M | Buy |
72,660
+39,944
| +122% | +$22.9M | 0.07% | 121 |
|
|
2021
Q4 | $21.8M | Buy |
32,716
+680
| +2% | +$425K | 0.04% | 175 |
|
|
2021
Q3 | $18.3M | Buy |
32,036
+273
| +0.9% | +$150K | 0.03% | 184 |
|
|
2021
Q2 | $16M | Sell |
31,763
-5,567
| -15% | -$2.63M | 0.03% | 198 |
|
|
2021
Q1 | $17M | Buy |
37,330
+1,570
| +4% | +$749K | 0.03% | 193 |
|
|
2020
Q4 | $16.7M | Buy |
35,760
+1,221
| +4% | +$572K | 0.04% | 183 |
|
|
2020
Q3 | $15.3M | Buy |
34,539
+5,011
| +17% | +$2.07M | 0.04% | 168 |
|
|
2020
Q2 | $10.7M | Sell |
29,528
-5
| -0% | -$1.68K | 0.03% | 183 |
|
|
2020
Q1 | $8.38M | Sell |
29,533
-340
| -1% | -$107K | 0.03% | 183 |
|
|
2019
Q4 | $9.71M | Buy |
29,873
+575
| +2% | +$174K | 0.03% | 193 |
|
|
2019
Q3 | $8.53M | Sell |
29,298
-1,191
| -4% | -$341K | 0.03% | 204 |
|
|
2019
Q2 | $8.95M | Buy |
30,489
+1,369
| +5% | +$377K | 0.03% | 196 |
|
|
2019
Q1 | $7.97M | Buy |
29,120
+674
| +2% | +$168K | 0.03% | 201 |
|
|
2018
Q4 | $6.37M | Buy |
28,446
+1,831
| +7% | +$430K | 0.03% | 206 |
|
|
2018
Q3 | $6.5M | Buy |
26,615
+1,385
| +5% | +$319K | 0.02% | 229 |
|
|
2018
Q2 | $5.23M | Buy |
25,230
+1,977
| +9% | +$420K | 0.02% | 247 |
|
|
2018
Q1 | $4.8M | Buy |
23,253
+233
| +1% | +$48.9K | 0.02% | 254 |
|
|
2017
Q4 | $4.37M | Buy |
23,020
+2,592
| +13% | +$497K | 0.02% | 267 |
|
|
2017
Q3 | $3.87M | Buy |
20,428
+3,433
| +20% | +$622K | 0.02% | 288 |
|
|
2017
Q2 | $2.96M | Sell |
16,995
-248
| -1% | -$41.7K | 0.02% | 329 |
|
|
2017
Q1 | $2.65M | Sell |
17,243
-1,085
| -6% | -$166K | 0.01% | 346 |
|
|
2016
Q4 | $2.59M | Buy |
18,328
+2,007
| +12% | +$296K | 0.02% | 329 |
|
|
2016
Q3 | $2.6M | Buy |
16,321
+3,744
| +30% | +$577K | 0.02% | 325 |
|
|
2016
Q2 | $1.86M | Buy |
12,577
+3,255
| +35% | +$480K | 0.01% | 349 |
|
|
2016
Q1 | $1.32M | Sell |
9,322
-1,696
| -15% | -$227K | 0.01% | 420 |
|
|
2015
Q4 | $1.56M | Sell |
11,018
-459
| -4% | -$61.2K | 0.01% | 371 |
|
|
2015
Q3 | $1.4M | Buy |
11,477
+1,268
| +12% | +$165K | 0.01% | 381 |
|
|
2015
Q2 | $1.32M | Sell |
10,209
-194
| -2% | -$25.3K | 0.01% | 391 |
|
|
2015
Q1 | $1.4M | Sell |
10,403
-2,079
| -17% | -$268K | 0.01% | 360 |
|
|
2014
Q4 | $1.56M | Buy |
12,482
+3,238
| +35% | +$394K | 0.02% | 329 |
|
|
2014
Q3 | $1.13M | Buy |
9,244
+1,418
| +18% | +$172K | 0.01% | 362 |
|
|
2014
Q2 | $923K | Buy |
7,826
+574
| +8% | +$67.6K | 0.01% | 411 |
|
|
2014
Q1 | $872K | Sell |
7,252
-185
| -2% | -$22K | 0.01% | 418 |
|
|
2013
Q4 | $828K | Buy |
7,437
+536
| +8% | +$53.3K | 0.01% | 361 |
|
|
2013
Q3 | $636K | Buy |
6,901
+522
| +8% | +$47.2K | 0.01% | 376 |
|
|
2013
Q2 | $540K | Buy |
+6,379
| New | +$531K | 0.01% | 386 |
|
Other funds holding TMO
VCM
Creative Planning's TMO Position: Q1 2026 in Review
Creative Planning increased its Thermo Fisher Scientific (TMO) stake by 4.1% in Q1 2026, buying an estimated $2.76M and bringing the position to 129,348 shares worth $63.6M. The position accounts for 0.04% of the portfolio, ranked #182.
Creative Planning first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $72M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Creative Planning held 129,348 shares of Thermo Fisher Scientific worth $63.6M as of Q1 2026.
- Creative Planning bought 5,093 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.76M.
- Thermo Fisher Scientific made up 0.04% of Creative Planning's portfolio in Q1 2026, its #182 holding.
- Creative Planning first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Creative Planning's Thermo Fisher Scientific position peaked at $72M in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.